Health
Final Results from REPRISE III: Long-Term Stroke Risk after TAVR for Severe Aortic Stenosis – DocWire News
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results…
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results from the REPRISE III randomized trial, which assessed the Lotus Valve transcatheter aortic valve replacement (TAVR) system…
Continue Reading
-
General13 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News21 hours agoStudents say new facility would be better in rural areas of Queensland
-
General15 hours ago‘We are here for you’: PM to bring help to flood zones
-
General10 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains